Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

BACKGROUND: Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Vitale, Maria Giuseppa, Scagliarini, Sarah, Galli, Luca, Pignata, Sandro, Lo Re, Giovanni, Berruti, Alfredo, Defferrari, Carlotta, Spada, Massimiliano, Masini, Cristina, Santini, Daniele, Ciuffreda, Libero, Ruggeri, Enzo Maria, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Giustini, Lucio, Hamzaj, Alketa, Procopio, Giuseppe, Caserta, Claudia, Sabbatini, Roberto
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://ncbi.nlm.nih.gov/pubmed/29979712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0199642
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller